Perinatal outcome following oxytocin administration (a prospective study).
D036861:Delivery, Obstetric / Q000379:methods; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced* / Q000453:epidemiology; D007751:Labor, Induced / Q000379:methods; D010121:Oxytocin / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D011446:Prospective Studies; D012306:Risk
D010121:Oxytocin